Phreesia, Inc. (0A23.L)

USD 28.5

(-1.96%)

Revenue Summary of Phreesia, Inc.

  • Phreesia, Inc.'s latest annual revenue in 2024 was 356.29 Million USD , up 26.84% from previous year.
  • Phreesia, Inc.'s latest quarterly revenue in 2024 FY was 356.29 Million USD , up 26.84% from previous quarter.
  • Phreesia, Inc. reported a annual revenue of 280.91 Million USD in annual revenue 2023, up 31.74% from previous year.
  • Phreesia, Inc. reported a annual revenue of 213.23 Million USD in annual revenue 2022, up 43.42% from previous year.
  • Phreesia, Inc. reported a quarterly revenue of 356.29 Million USD for 2024 FY, up 26.84% from previous quarter.
  • Phreesia, Inc. reported a quarterly revenue of 85.83 Million USD for 2024 Q2, up 2.37% from previous quarter.

Annual Revenue Chart of Phreesia, Inc. (2024 - 2018)

Historical Annual Revenue of Phreesia, Inc. (2024 - 2018)

Year Revenue Revenue Growth
2024 356.29 Million USD 26.84%
2023 280.91 Million USD 31.74%
2022 213.23 Million USD 43.42%
2021 148.67 Million USD 19.15%
2020 124.78 Million USD 24.92%
2019 99.88 Million USD 25.12%
2018 79.83 Million USD 0.0%

Peer Revenue Comparison of Phreesia, Inc.

Name Revenue Revenue Difference
Accuray Incorporated 446.55 Million USD 20.211%
Align Technology, Inc. 3.86 Billion USD 90.775%
Elevance Health Inc. 171.34 Billion USD 99.792%
AxoGen, Inc. 159.01 Million USD -124.071%
Boston Scientific Corporation 14.24 Billion USD 97.498%
CVS Health Corporation 357.77 Billion USD 99.9%
Cardinal Health, Inc. 226.82 Billion USD 99.843%
Centene Corporation 141.26 Billion USD 99.748%
DaVita Inc. 12.14 Billion USD 97.065%
HCA Healthcare, Inc. 64.96 Billion USD 99.452%
Hologic, Inc. 4.03 Billion USD 91.159%
Humana Inc. 106.37 Billion USD 99.665%
IDEXX Laboratories, Inc. 3.66 Billion USD 90.268%
Laboratory Corporation of America Holdings 12.16 Billion USD 97.07%
Masimo Corporation 2.04 Billion USD 82.603%
McKesson Corporation 308.95 Billion USD 99.885%
Patterson Companies, Inc. 6.56 Billion USD 94.575%
Quest Diagnostics Incorporated 9.25 Billion USD 96.149%
ResMed Inc. 4.68 Billion USD 92.395%
Henry Schein, Inc. 12.33 Billion USD 97.112%
Teladoc Health, Inc. 2.6 Billion USD 86.309%
Universal Health Services, Inc. 14.28 Billion USD 97.505%
Veeva Systems Inc. 2.36 Billion USD 84.926%
Baxter International Inc. 14.81 Billion USD 97.595%
Becton, Dickinson and Company 19.37 Billion USD 98.161%
Intuitive Surgical, Inc. 7.12 Billion USD 94.999%
Danaher Corporation 23.89 Billion USD 98.509%
Stryker Corporation 20.49 Billion USD 98.262%
Medtronic plc 32.36 Billion USD 98.899%